Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

Published:2021-06 Issue:6 Volume:79 Page:722-733
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Ruiz de Porras Vicenç,Wang Xieng C.,Palomero Luis,Marin-Aguilera Mercedes,Solé-Blanch Carme,Indacochea Alberto,Jimenez Natalia,Bystrup Sara,Bakht Martin,Conteduca Vincenza,Piulats Josep M.,Buisan Oscar,Suarez José F.,Pardo Juan Carlos,Castro Elena,Olmos David,Beltran Himisha,Mellado Begoña,Martinez-Balibrea Eva,Font Albert,Aytes Alvaro

Funder

U.S. Department of Defense

Instituto de Salud Carlos III

European Association of Urology

Publisher

Elsevier BV

Subject

Urology

Reference33 articles.

1. Prostate cancer;Attard;Lancet,2016

2. Metastatic prostate cancer;Sartor;N Engl J Med,2018

3. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology;Nuhn;Eur Urol,2019

4. Aggressive variants of castration-resistant prostate cancer;Beltran;Clin Cancer Res,2014

5. Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer;Labrecque;J Clin Invest,2019

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation in cancer, anticancer therapies, and underlying mechanisms;Journal of Molecular and Cellular Cardiology;2024-09

2. The CXCR2 chemokine receptor: A new target for gastric cancer therapy;Cytokine;2024-09

3. Synthesis of selective BCL-XL PROTAC and potent antitumor activity in glioblastoma;2024-08-19

4. Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy;Pharmaceuticals;2024-08-05

5. Antimicrobial and anticancer activities of diazenyl compounds;Results in Chemistry;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3